edited by Jean-Claude Tardif, Martial G. Bourassa.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Dordrecht
Name of Publisher, Distributor, etc.
Springer Netherlands
Date of Publication, Distribution, etc.
2000
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xii, 258 pages)
SERIES
Series Title
Developments in cardiovascular medicine, 233.
CONTENTS NOTE
Text of Note
1. Lipoproteins and Oxidation: Clinical Aspects of Lipoprotein Metabolism and Oxidation --; 2. Pathogenesis of Artherosclerosis --; 3. The Antioxidant Hypothesis --; 4. Reactive Oxygen Species as Mediators of Signal Transduction in Cardiovascular Disease --; 5. Pharmaceutical Compounds with Antioxidant Activity --; 6. Nutrition and Antioxidants --; 7. Antioxidants and Vascular Disease: Animal Studies --; 8. Antioxidants and Endothelial Function --; Human Studies --; 9. Antioxidant Vitamins and Cardiovascular Disease: Evidence from Observational Epidemiologic Studies and Randomized Trials --; 10. A Rationale for Antioxidant Use in Cardiovascular Disease --; 11. Antioxidants and Restenosis --; Animal Studies --; 12. Antioxidants and Restenosis --; Human Studies --; 13. Role of Oxidative Stress, Cytokines and Apoptosis in Myocardial Dysfunction --; 14. Oxidative Stress and Use of Antioxidants in Patients with Congestive Heart Failure --; 15. Use of Antioxidants in Cardiovascular Medicine --; Appendix Update on Recently Completed Clinical Trials on Antioxidants and Cardiovascular Diseases.
SUMMARY OR ABSTRACT
Text of Note
This book addresses a complex but very timely and fascinating problem in cardiovascular medicine. It is written by recognized experts in the fields of atherosclerosis, heart failure, and antioxidants. It should be of interest not only to academicians but to practising physicians, including postdoctoral fellows, internists, cardiologists, and general practitioners. The first three chapters review the antioxidant hypothesis and its close relationship to lipid metabolism and pathogenesis of atherosclerosis. The subsequent chapters define the mechanisms of action and classify the different and heterogeneous pharmacological compounds with known antioxidant properties, and describe the role of dietary nutrients and supplements as well as the potential therapeutic benefit of antioxidants in coronary artery disease prevention and risk reduction, prevention of endothelial dysfunction, and prevention of coronary restenosis after percutaneous coronary interventions and treatment and prevention of chronic heart failure. Finally, current knowledge of the use of these compounds in cardiovascular medicine is summarized.
TOPICAL NAME USED AS SUBJECT
Cardiology.
Medicine.
Nutrition.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC669
.
9
Book number
E358
2000
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Jean-Claude Tardif, Martial G. Bourassa.